Introduction Pregnant women are more vulnerable to malaria leading to adverse impact on
both mothers and fetuses. However, knowledge on the efficacy and safety of antimalarials in …

Background Malaria in pregnancy affects both the mother and the fetus. However, evidence
supporting treatment guidelines for uncomplicated (including asymptomatic) falciparum …

Background There is no agreed standard method to assess the efficacy of anti-malarials for
uncomplicated falciparum in pregnancy despite an increased risk of adverse outcomes for …

Background Malaria in pregnancy, including asymptomatic infection, has a detrimental
impact on foetal development. Individual patient data (IPD) meta-analysis was conducted to …

Abstract The World Health Organization recommends artemisinin-based combination
therapies (ACTs) for the treatment of uncomplicated falciparum malaria in the second and …

Background Considering the uncertainty of safety of anti-malarial drugs in pregnancy,
efficacy studies are one of the few sources of clinical safety data. Complete safety evaluation …

Background Women are more vulnerable to malaria during pregnancy, and malaria infection
may have adverse consequences for the fetus. Identifying safe and effective treatments is …

All malaria infections are harmful to both the pregnant mother and the developing fetus. One
in ten maternal deaths in malaria endemic countries are estimated to result from …

Introduction: With increasing parasite drug resistance, the WHO has updated treatment
recommendations for falciparum malaria including in pregnancy. This review assesses the …

Background Malaria in pregnancy is associated with maternal and fetal morbidity and
mortality. In 2006, WHO recommended use of artemisinin-based combination treatments …